can you take glp 1 if you have gastroparesis Lawsuit - Ozempic, Wegovy & Mounjaro GLP-1 and Gastroparesis: Clinical Safety

Description

At least one analysis found the drugs to be cost effective, but employers have balked at paying for them because so many people could be eligible for the treatments and many patients stop them after achieving a weight loss goal

In this episode, Michael sits down with Patrick Sullivan Jr

Women who choose microdosing usually want: Weight maintenance Longevity A slower and softer appetite change Time to build habits while easing in A way to minimize nausea or digestive side effects Women who choose a full therapeutic dose usually want: A more noticeable appetite shift sooner Strong hunger control to stay consistent A clearer and faster momentum with weight loss Both paths can be effective during menopause, and neither is better. The choice is about comfort level and sensitivity , not willpower or motivation

For example, if your genetic markers suggest stronger GIP pathway sensitivity, tirzepatide may produce faster results than semaglutide alone

While GLP-1 receptor agonists have a relatively wide safety margin, exceeding recommended doses or escalating too quickly can trigger severe adverse effects including acute pancreatitis, severe dehydration, and gastrointestinal damage